These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 34782274)

  • 1. Plaque-type psoriasis inhibitors.
    Shobeiri SS; Khorrami M; Sankian M
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108326. PubMed ID: 34782274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultraviolet Phototherapy Management of Moderate-to-Severe Plaque Psoriasis: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(27):1-66. PubMed ID: 23074532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Garcia-Doval I; Do G; Hua C; Mazaud C; Droitcourt C; Hughes C; Ingram JR; Naldi L; Chosidow O; Le Cleach L
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011535. PubMed ID: 29271481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease and treatment burden of psoriasis: examining the impact of biologics.
    Raval K; Lofland JH; Waters H; Piech CT
    J Drugs Dermatol; 2011 Feb; 10(2):189-96. PubMed ID: 21283925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A real-world economic analysis of biologic therapies for moderate-to-severe plaque psoriasis in Italy: results of the CANOVA observational longitudinal study.
    Zagni E; Bianchi L; Fabbrocini G; Corrao S; Offidani A; Stingeni L; Costanzo A; Pellacani G; Peris K; Bardazzi F; Argenziano G; Ruffolo S; Dapavo P; Carrera C; Fargnoli MC; Parodi A; Romanelli M; Malagoli P; Talamonti M; Megna M; Raspanti M; Paolinelli M; Hansel K; Narcisi A; Conti A; De Simone C; Chessa MA; De Rosa A; Provenzano E; Ortoncelli M; Moltrasio C; Fidanza R; Burlando M; Tonini A; Gaiani FM; Simoni L; Zullo A; Fiocchi M; Colombo D
    BMC Health Serv Res; 2021 Sep; 21(1):924. PubMed ID: 34488749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and Under Development Treatment Modalities of Psoriasis: A Review.
    Albaghdadi A
    Endocr Metab Immune Disord Drug Targets; 2017; 17(3):189-199. PubMed ID: 28782467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologics for the primary care physician: Review and treatment of psoriasis.
    Schadler ED; Ortel B; Mehlis SL
    Dis Mon; 2019 Mar; 65(3):51-90. PubMed ID: 30037762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging systemic drugs in the treatment of plaque psoriasis.
    Balogh EA; Bashyam AM; Ghamrawi RI; Feldman SR
    Expert Opin Emerg Drugs; 2020 Jun; 25(2):89-100. PubMed ID: 32192366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging landscape in psoriasis management: From topical application to targeting biomolecules.
    Rapalli VK; Singhvi G; Dubey SK; Gupta G; Chellappan DK; Dua K
    Biomed Pharmacother; 2018 Oct; 106():707-713. PubMed ID: 29990862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical therapy for psoriasis: a promising future. Focus on JAK and phosphodiesterase-4 inhibitors.
    Rafael A; Torres T
    Eur J Dermatol; 2016; 26(1):3-8. PubMed ID: 26552963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologic Therapy Utilization in Patients With Moderate to Severe Psoriasis and Psoriatic Arthritis: An Observational Summary of Biologic Therapy Use in a Clinical Setting.
    Gulliver WP; Randell S; Gulliver S; Gregory V; Nagle S; Chambenoit O
    J Cutan Med Surg; 2018; 22(6):567-576. PubMed ID: 29952225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term use of adalimumab in the treatment of moderate to severe plaque psoriasis: a review of the literature.
    Moore AY; Richardson BS
    Clin Cosmet Investig Dermatol; 2010 Apr; 3():49-58. PubMed ID: 21437059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Psoriasis in the era of biologics].
    Torres T; Velho GC; Sanches M; Selores M
    Acta Med Port; 2010; 23(3):493-8. PubMed ID: 20654269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term safety of biologics in the treatment of moderate-to-severe plaque psoriasis: review of current data.
    Rustin MH
    Br J Dermatol; 2012 Nov; 167 Suppl 3():3-11. PubMed ID: 23082810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of moderate and severe psoriasis.
    Claes C; Kulp W; Greiner W; von der Schulenburg JM; Werfel T
    GMS Health Technol Assess; 2006 Apr; 2():Doc07. PubMed ID: 21289958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current and emerging systemic treatment strategies for psoriasis.
    Laws PM; Young HS
    Drugs; 2012 Oct; 72(14):1867-80. PubMed ID: 22938141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advancements in the treatment of psoriasis: role of biologic agents.
    Rich SJ; Bello-Quintero CE
    J Manag Care Pharm; 2004; 10(4):318-25. PubMed ID: 15298530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in the treatment of moderate-to-severe plaque psoriasis.
    Herrier RN
    Am J Health Syst Pharm; 2011 May; 68(9):795-806. PubMed ID: 21515863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Old and New Biological Therapies for Psoriasis.
    Rønholt K; Iversen L
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29104241
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.